Chade Alejandro R, Tharp Darla L, Sitz Rhys, McCarthy Elizabeth A, Shivam Kumar, Kazeminia Sara, Eirin Alfonso
The Department of Medical Pharmacology and Physiology, University of Missouri-Columbia, Columbia, Missouri, USA.
The Department of Medicine, University of Missouri-Columbia, Columbia, Missouri, USA.
Am J Nephrol. 2025;56(3):337-350. doi: 10.1159/000543327. Epub 2025 Jan 2.
Chronic kidney disease (CKD) and heart failure with preserved ejection fraction (HFpEF) are more prevalent in the elderly. There is a lack of large animal models that allow the study of the impact of age on CKD and HFpEF in a translational fashion. This manuscript reports the first large preclinical model of CKD-HFpEF and metabolic derangements in naturally aged swine.
CKD-HFpEF was induced in naturally aged (6-9 years old) and young (3 months old) pigs, followed for 14 weeks, and compared to normal young and old controls (n = 5/group). Renal and cardiac hemodynamics were quantified in vivo by multidetector-CT, echocardiography, and pressure-volume relationship studies. Renal and cardiac microvascular (MV) architecture (3D-micro-CT) and morphometric analysis (staining) were investigated ex vivo.
Both young and old pigs developed CKD-HFpEF, but the renal, cardiac, and metabolic phenotype was accentuated in aging animals. Aging and CKD-HFpEF influenced fasting insulin levels and insulin resistance, glomerular filtration rate, cortical MV density, glomerulosclerosis, perivascular fibrosis, and tubular injury. Tubule-interstitial fibrosis and peritubular capillary density were influenced by aging, CKD-HFpEF, and their interaction (2-way ANOVA). Similarly, cardiac MV density, perivascular fibrosis, and myocardial remodeling were influenced by aging and CKD-HFpEF, and E/A by their interaction. Notably, renal and cardiac MV density correlated with renal and cardiac functional and structural changes.
Our study establishes the first large animal model of aging CKD-HFpEF, allowing the investigation of age as a biological variable in cardiorenal and metabolic diseases. This new platform could foster new age-related research toward developing therapeutic interventions in CKD-HFpEF.
慢性肾脏病(CKD)和射血分数保留的心力衰竭(HFpEF)在老年人中更为普遍。缺乏能够以转化方式研究年龄对CKD和HFpEF影响的大型动物模型。本手稿报告了首个自然衰老猪的CKD-HFpEF及代谢紊乱的大型临床前模型。
在自然衰老(6至9岁)和年轻(3个月大)的猪中诱导CKD-HFpEF,持续观察14周,并与正常年轻和老年对照进行比较(每组n = 5)。通过多排CT、超声心动图和压力-容积关系研究对肾脏和心脏血流动力学进行体内定量分析。离体研究肾脏和心脏微血管(MV)结构(三维微CT)和形态计量分析(染色)。
年轻和老年猪均发展为CKD-HFpEF,但衰老动物的肾脏、心脏和代谢表型更为明显。衰老和CKD-HFpEF影响空腹胰岛素水平和胰岛素抵抗、肾小球滤过率、皮质MV密度、肾小球硬化、血管周围纤维化和肾小管损伤。肾小管间质纤维化和肾小管周围毛细血管密度受衰老、CKD-HFpEF及其相互作用的影响(双向方差分析)。同样,心脏MV密度、血管周围纤维化和心肌重塑受衰老和CKD-HFpEF的影响,E/A受其相互作用的影响。值得注意的是,肾脏和心脏MV密度与肾脏和心脏功能及结构变化相关。
我们的研究建立了首个衰老CKD-HFpEF的大型动物模型,能够将年龄作为心脏肾脏和代谢疾病中的一个生物学变量进行研究。这个新平台可能会促进与年龄相关的新研究,以开发针对CKD-HFpEF的治疗干预措施。